Tapewire

Nasdaq · USD

MRKR

Marker Therapeutics, Inc.

Export transactions ↓
Tapewire entity
7609
SEC CIK
0001094038
Parsed reports
150

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 12, 2016 Filed Dec 14, 2016 21:31 UTC
BONFIGLIO JOHN NDirector · President and COO
Exercise / conversionCommon Stock 10,417 $1.74 $18,125.58
Disclosure

SEC source: 0001144204-16-139495 · v455027_4.xml · nonDerivative · entry 1

BONFIGLIO JOHN N · CIK 0001222253 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,251

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents a partial exercise of a stock option award under the Company's 2014 Omnibus Stock Ownership Plan (the "Plan") originally granted in connection with services to the Company as a consultant. The options fully vested on January 31, 2016. In connection with the exercise of the options, Reporting Person transferred the shares to his spouse.

Read SEC document
November 28, 2016 Filed Nov 30, 2016 21:49 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $4.82 $0.00
Disclosure

SEC source: 0001524858-16-000009 · primary_doc.xml · derivative · entry 1

Silverman Joshua · CIK 0001524858 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2026-11-27

F1 · security: Represents options granted in connection with appointment as a director of the Company on November 28, 2016 under the Company's 2014 Omnibus Stock Ownership Plan. These shares shall vest in monthly installments over a two year period. The option exercise price is the closing price on the date of the grant, November 28, 2016.

F1 · derivative.exercise_date: Represents options granted in connection with appointment as a director of the Company on November 28, 2016 under the Company's 2014 Omnibus Stock Ownership Plan. These shares shall vest in monthly installments over a two year period. The option exercise price is the closing price on the date of the grant, November 28, 2016.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.